soul trial oral semaglutide cardiovascular outcomes results 2024 SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with Clinical Effectiveness and Safety of
Description
Cause 1: Hypoglycemia Hypoglycemia is one of two primary causes of dizziness or lightheadedness on semaglutide, particularly for patients taking GLP-1s and insulin or sulfonylurea to manage their diabetes symptoms
Frontiers in Behavioral Neuroscience
The FDA reviewed these differences during the approval process and determined they do not require dose adjustments based on injection location
Research consistently shows that appropriate fueling of carbohydrate, fat, and protein will help to energize and achieve ones fitness goals
